Preambles to 21 CFR Part 111

Preambles are the notes that FDA publishes when it announces a proposed or final rule. They respond to comments submitted by industry and the public, and often reveal the intent and FDA's interpretation of the regulation. All preamble files are in PDF format, and require Adobe Acrobat Reader to view.

  • 73 FR 27727 (24 May 2007)
    The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of June 25, 2007 (72 FR 34752). The final rule established current good manufacturing practice (CGMP) requirements in manufacturing, packaging, labeling, or holding operations for dietary supplements. The final rule was published with an inadvertent error in the codified section. This document corrects that error.

Return to GMP Regulations and Preambles